Genmab A/S (GNMSF) Capital expenditures 2023–2025
Genmab A/S (GNMSF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$37.0MFY2025 · since FY2023: $53.0M → $37.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $37.0M | +37.0% |
| FY2024 | $27.0M | -49.1% |
| FY2023 | $53.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More GNMSF financial trends
GNMSF RevenueGNMSF Net incomeGNMSF Net marginGNMSF Gross profitGNMSF Gross marginGNMSF Operating incomeGNMSF Operating marginGNMSF Operating cash flowGNMSF Free cash flowGNMSF Return on equityGNMSF Stock buybacksGNMSF Dividends paidGNMSF Total assetsGNMSF Total liabilitiesGNMSF Shareholders’ equityGNMSF overview →